Pfizer has committed to providing $4 million to enable the North Carolina Biotechnology Center to establish and administer a multi-year academic fellowship program to help advance the state's gene therapy expertise.
The Council for Entrepreneurial Development has picked North Carolina life science pacesetter Art Pappas, managing partner of venture capital firm Pappas Ventures, to receive its 2017 Life Science Leadership Award.
When Nancy Rosborough read an article in the Washington Post about growing truffles, a gourmet delicacy that’s normally harvested from the wild, the novel idea took root as a Burlington biotech company.
Raleigh bioscience startup Locus Biosciences, a spinout of North Carolina State University, is using a version of the hot gene-editing technology called CRISPR to cut a new path to the discovery and development of novel antibiotics.
It was a gray afternoon in March, 2008 at the North Carolina Biotechnology Center. A kindly looking gentleman stood in our Congressional Room, surrounded by a group of North Carolina’s brightest young scientists, winners of various science competitions across the state that year.
Two former commissioners of the U.S. Food and Drug Administration, both with ties to Duke University, are among the speakers headlining the Council for Entrepreneurial Development’s 26th annual Life Science Conference in Raleigh Feb. 28 and March 1.